Metabolix (NASDAQ: MBLX) had its target price lifted by Jefferies Group from $1.50 to $2.30 in a research note issued to investors on Wednesday. The firm currently has a hold rating on the stock.
Shares of Metabolix traded up 1.72% during mid-day trading on Wednesday, hitting $2.37. Metabolix has a 52 week low of $1.07 and a 52 week high of $3.48. The stock’s 50-day moving average is currently $1.83. The company has a market cap of $81.3 million and a P/E ratio of 24.02.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.
